Alfred Health

Melbourne, Victoria 3168

7 studies enrolling now · 35 studies all time

What they study most

Acute Myeloid Leukemia (AML), Advanced Melanoma, Advanced Solid Tumor, Advanced Solid Tumors, Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL), Alzheimer's Disease, Alzheimers Disease, B-cell Lymphoma, B-cell Malignancy, Basal Cell Carcinoma, Breast Cancer, Candidemia

Studies at this site

• Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies — Recruiting now
• A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation — Recruiting now
• A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions — Recruiting now
• IKS014 in Advanced Solid Tumors That Express HER2 — Recruiting now
• A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1) — Recruiting now
• Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) — Recruiting now
• A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies — Recruiting now
• Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome — Running, not enrolling
• Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease — Enrolling by invitation
• A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis — Running, not enrolling
• RESEARCH EVALUATING VAGAL EXCITATION AND ANATOMICAL LINKS — Running, not enrolling
• A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer — Running, not enrolling
• A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation — Running, not enrolling
• (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma — Running, not enrolling
• Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01 — Running, not enrolling
• A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease — Stopped early
• IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma — Running, not enrolling
• A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache — Completed
• A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies — Completed
• Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma — Completed
• A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib — Running, not enrolling
• Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy — Completed
• A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors — Running, not enrolling
• Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma — Stopped early
• ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension — Stopped early
• Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease. — Completed
• Efficacy and Safety of XT-150 in Osteoarthritis of the Knee — Completed
• Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies — Completed
• Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis — Stopped early
• Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis — Completed
• Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease — Stopped early
• Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis — Stopped early
• Evaluation of a Patient-Reported Symptom Index for NMIBC — Completed
• Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2) — Stopped early